1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RBM20 CTRPv2 pan-cancer AAC -0.093 0.01
mRNA BIRC3 CTRPv2 pan-cancer AAC -0.087 0.01
mRNA MMP8 CTRPv2 pan-cancer AAC 0.1 0.01
mRNA PIF1 CTRPv2 pan-cancer AAC -0.092 0.01
mRNA C11orf57 CTRPv2 pan-cancer AAC -0.095 0.01
mRNA FAM160A2 CTRPv2 pan-cancer AAC 0.094 0.01
mRNA ESRP1 CTRPv2 pan-cancer AAC 0.1 0.01
mRNA NOTCH1 CTRPv2 pan-cancer AAC 0.089 0.01
mRNA ACRBP CTRPv2 pan-cancer AAC 0.09 0.01
mRNA SPATA3 CTRPv2 pan-cancer AAC 0.085 0.01
Download CSV